Detail Information of Xenobiotics-driven Alterations in 3D Complexes
| General Information of Drug Transporter (DT) | |||||
|---|---|---|---|---|---|
| DT ID | DTD0002 Transporter Info | ||||
| Gene Name | ABCC2 | ||||
| Transporter Name | Multidrug resistance-associated protein 2 | ||||
| Gene ID | |||||
| UniProt ID | |||||
| Xenobiotics-driven Alterations in 3D Complexes (XSV) of This DT | |||||
| Xenobiotic Name | Cefamandole Drug Info | ||||
| Xenobiotic Type | Approved Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 456255 | ||||
| Docking Score | -10.765 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C18H18N6O5S2 | ||||
| Molecular Weight | 462.5 | ||||
| Canonical SMILES |
CN1C(=NN=N1)SCC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)[C@@H](C4=CC=CC=C4)O)SC2)C(=O)O
|
||||
| InChI |
InChI=1S/C18H18N6O5S2/c1-23-18(20-21-22-23)31-8-10-7-30-16-11(15(27)24(16)12(10)17(28)29)19-14(26)13(25)9-5-3-2-4-6-9/h2-6,11,13,16,25H,7-8H2,1H3,(H,19,26)(H,28,29)/t11-,13-,16-/m1/s1
|
||||
| InChIKey | OLVCFLKTBJRLHI-AXAPSJFSSA-N | ||||
| Pharmaceutical Properties | Xlogp | -0.9 | Rotatable Bond Count | 7 | |
| Hydrogen Bond Donor Count | 3 | Hydrogen Bond Acceptor Count | 10 | ||
| Xenobiotic Name | Ritonavir Drug Info | ||||
| Xenobiotic Type | Approved Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 392622 | ||||
| Docking Score | -10.636 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C37H48N6O5S2 | ||||
| Molecular Weight | 720.9 | ||||
| Canonical SMILES |
CC(C)C1=NC(=CS1)CN(C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC2=CC=CC=C2)C[C@@H]([C@H](CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O
|
||||
| InChI |
InChI=1S/C37H48N6O5S2/c1-24(2)33(42-36(46)43(5)20-29-22-49-35(40-29)25(3)4)34(45)39-28(16-26-12-8-6-9-13-26)18-32(44)31(17-27-14-10-7-11-15-27)41-37(47)48-21-30-19-38-23-50-30/h6-15,19,22-25,28,31-33,44H,16-18,20-21H2,1-5H3,(H,39,45)(H,41,47)(H,42,46)/t28-,31-,32-,33-/m0/s1
|
||||
| InChIKey | NCDNCNXCDXHOMX-XGKFQTDJSA-N | ||||
| Pharmaceutical Properties | Xlogp | 6 | Rotatable Bond Count | 18 | |
| Hydrogen Bond Donor Count | 4 | Hydrogen Bond Acceptor Count | 9 | ||
| Xenobiotic Name | Vinblastine Drug Info | ||||
| Xenobiotic Type | Approved Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 13342 | ||||
| Docking Score | -10.605 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C46H58N4O9 | ||||
| Molecular Weight | 811 | ||||
| Canonical SMILES |
CC[C@@]1(C[C@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
|
||||
| InChI |
InChI=1S/C46H58N4O9/c1-8-42(54)23-28-24-45(40(52)57-6,36-30(15-19-49(25-28)26-42)29-13-10-11-14-33(29)47-36)32-21-31-34(22-35(32)56-5)48(4)38-44(31)17-20-50-18-12-16-43(9-2,37(44)50)39(59-27(3)51)46(38,55)41(53)58-7/h10-14,16,21-22,28,37-39,47,54-55H,8-9,15,17-20,23-26H2,1-7H3/t28-,37-,38+,39+,42-,43+,44+,45-,46-/m0/s1
|
||||
| InChIKey | JXLYSJRDGCGARV-CFWMRBGOSA-N | ||||
| Pharmaceutical Properties | Xlogp | 3.7 | Rotatable Bond Count | 10 | |
| Hydrogen Bond Donor Count | 3 | Hydrogen Bond Acceptor Count | 12 | ||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.